Skip to main content
SpringerLink
Log in
Book cover

Cannabinoid Modulation of Emotion, Memory, and Motivation pp 443–470Cite as

Cannabinoid-Dopamine Interactions: Modulation of Midbrain DA Neurons by Endocannabinoids

  • Chapter
  • First Online:

  • 1494 Accesses

Abstract

A key feature of human and animal behavior is to learn from environmental stimuli to adapt efficiently. Under physiological conditions, dopaminergic (DA) neurons are used to evaluate and learn new sensory information and adjust behavior to maximize reward and minimize aversive consequences. The two main DA pathways in the mesencephalon originate from the substantia nigra pars compacta (SNpc) and the ventral tegmental area (VTA). Both in vivo and in vitro studies have established that DA neurons exhibit spontaneous spike firing that is driven by intrinsic electrophysiological properties, with their activity modulated by afferent inputs and a number of neuromodulators, including endocannabinoids. In the VTA and SNpc, cannabinoid type 1- (CB1) and ionotropic transient receptor potential vanilloid type 1 (TRPV1) receptors are abundantly expressed as well as their endogenous ligands, mainly anandamide and 2-arachidonoylglycerol. This chapter attempts to summarize some of the major research findings demonstrating that SNpc and VTA DA neurons vary significantly in their molecular and physiological properties according to target location, and that endocannabinoids act on GABAergic, glutamatergic and cholinergic terminals to participate in discrete mechanisms aimed at DA cell homeostatic regulation. As a result, given the role of the endocannabinoid system in modulating DA neuronal function of the SNpc and the VTA, they might take part in associative learning, reward signaling, goal directed behavior, motor skill learning and action-habit transformation. These considerations help explaining the correlation between an unbalanced endocannabinoid signal and altered DA-dependent processes underpinning diverse pathological conditions of both nigrostriatal and mesocorticolimbic systems.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Reference

  1. Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems. CNS Neurol Disord Drug Targets. 2013;12:70–7.

    Article  CAS  PubMed  Google Scholar 

  2. Melis M, Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philos Trans R Soc Lond B Biol Sci. 2012;367:3276–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Front Pharmacol. 2012;3:7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Fernandez-Ruiz J, Hernandez M, Ramos JA. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. CNS Neurosci Ther. 2010;16:e72–e91.

    Article  CAS  PubMed  Google Scholar 

  5. Melis M, Pistis P. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Curr Neuropharmacol. 2007;5:268–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Matyas F, Urban GM, Watanabe M, Mackie K, Zimmer A, Freund TF, Katona I. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology. 2008;54:95–107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kortleven C, Fasano C, Thibault D, Lacaille JC, Trudeau LE. The endocannabinoid 2-arachidonoylglycerol inhibits long-term potentiation of glutamatergic synapses onto ventral tegmental area dopamine neurons in mice. Eur J Neurosci. 2011;33:1751–60.

    Article  PubMed  Google Scholar 

  8. Marinelli S, Di Marzo V, Florenzano F, Fezza F, Viscomi MT, van der Stelt M, Bernardi G, Molinari M, Maccarrone M, Mercuri NB. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology. 2007;32:298–308.

    Article  CAS  PubMed  Google Scholar 

  9. Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol Dis. 2006;24:15–27.

    Article  CAS  PubMed  Google Scholar 

  10. Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, De Montis MG, Pistis M. PPARalpha regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving alpha7 nicotinic acetylcholine receptors. J Neurosci. 2013;33:6203–11.

    Article  CAS  PubMed  Google Scholar 

  11. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 1994;372:686–91.

    Article  CAS  PubMed  Google Scholar 

  12. Alger BE. Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know. J Physiol. 2012;590:2203–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev. 2009;89:309–80.

    Article  CAS  PubMed  Google Scholar 

  14. Katona I, Freund TF. Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci. 2012 35:529–58.

    Google Scholar 

  15. Castillo PE, Younts TJ, Chavez AE, Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron. 2012;76:70–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Heifets BD, Castillo PE. Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol. 2009;71:283–306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Abbott LF, Regehr WG. Synaptic computation. Nature. 2004;431:796–803.

    Article  CAS  PubMed  Google Scholar 

  18. Dittman JS, Kreitzer AC, Regehr WG. Interplay between facilitation, depression, and residual calcium at three presynaptic terminals. J Neurosci. 2000;20:1374–85.

    CAS  PubMed  Google Scholar 

  19. Klyachko VA, Stevens CF. Excitatory and feed-forward inhibitory hippocampal synapses work synergistically as an adaptive filter of natural spike trains. PLoS Biol. 2006;4:e207.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Fortune ES, Rose GJ. Short-term synaptic plasticity as a temporal filter. Trends Neurosci. 2001;24:381–5.

    Article  CAS  PubMed  Google Scholar 

  21. Lewis JE, Maler L. Dynamics of electrosensory feedback: short-term plasticity and inhibition in a parallel fiber pathway. J Neurophysiol. 2002;88:1695–706.

    PubMed  Google Scholar 

  22. Abbott LF, Varela JA, Sen K, Nelson SB. Synaptic depression and cortical gain control. Science. 1997;275:220–4.

    Article  CAS  PubMed  Google Scholar 

  23. Yanovsky Y, Mades S, Misgeld U. Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra. Neuroscience. 2003;122:317–28.

    Article  CAS  PubMed  Google Scholar 

  24. Freestone PS, Guatteo E, Piscitelli F, di Marzo V, Lipski J, Mercuri NB. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta. Neuropharmacology. 2013;79C:467–75.

    Google Scholar 

  25. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 1998;80:1–27.

    CAS  PubMed  Google Scholar 

  26. Wise RA. Dopamine, learning and motivation. Nat Rev Neurosci. 2004;5:483–94.

    Article  CAS  PubMed  Google Scholar 

  27. Matsumoto M, Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature. 2009;459:837–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Schultz W. Behavioral dopamine signals. Trends Neurosci. 2007;30:203–10.

    Article  CAS  PubMed  Google Scholar 

  29. Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci. 2006;26:2788–97.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron. 2008;57:760–73.

    Article  CAS  PubMed  Google Scholar 

  31. Margolis EB, Lock H, Hjelmstad GO, Fields HL. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol. 2006;577:907–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Ilango A, Kesner AJ, Keller KL, Stuber GD, Bonci A, Ikemoto S. Similar roles of substantia nigra and ventral tegmental dopamine neurons in reward and aversion. J Neurosci. 2014;34:817–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Brischoux F, Chakraborty S, Brierley DI, Ungless MA. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci U S A. 2009;106:4894–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem. 1989;52:1655–8.

    Article  CAS  PubMed  Google Scholar 

  35. Kalivas PW, Churchill L, Romanides A. Involvement of the pallidal-thalamocortical circuit in adaptive behavior. Ann N Y Acad Sci. 1999;877:64–70.

    Article  CAS  PubMed  Google Scholar 

  36. Kalivas PW, Nakamura M. Neural systems for behavioral activation and reward. Curr Opin Neurobiol. 1999;9:223–7.

    Article  CAS  PubMed  Google Scholar 

  37. Barr GA, Moriceau S, Shionoya K, Muzny K, Gao P, Wang S, Sullivan RM. Transitions in infant learning are modulated by dopamine in the amygdala. Nat Neurosci. 2009;12:1367–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pezze MA, Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol. 2004;74:301–20.

    Article  CAS  PubMed  Google Scholar 

  39. Takahata R, Moghaddam B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J Neurochem. 2000;75:1775–8.

    Article  CAS  PubMed  Google Scholar 

  40. Lammel S, Ion DI, Roeper J, Malenka RC. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron. 2011;70:855–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lammel S, Lim BK, Ran C, Huang KW, Betley MJ, Tye KM, Deisseroth K, Malenka RC. Input-specific control of reward and aversion in the ventral tegmental area. Nature. 2012;491:212–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Roeper J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci. 2013;36:336–42.

    Article  CAS  PubMed  Google Scholar 

  43. Nair-Roberts RG, Chatelain-Badie SD, Benson E, White-Cooper H, Bolam JP, Ungless MA. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience. 2008;152:1024–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Henny P, Brown MT, Northrop A, Faunes M, Ungless MA, Magill PJ, Bolam JP. Structural correlates of heterogeneous in vivo activity of midbrain dopaminergic neurons. Nat Neurosci. 2012;15:613–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Dobi A, Margolis EB, Wang HL, Harvey BK, Morales M. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci. 2010;30:218–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Li SX, Wei YM, Shi HS, Luo YX, Ding ZB, Xue YX, Lu L, Yu CX. Glycogen synthase kinase-3beta in the ventral tegmental area mediates diurnal variations in cocaine-induced conditioned place preference in rats. Addict Biol. 2014;19(6):996–1005.

    Google Scholar 

  47. Spiga S, Serra GP, Puddu MC, Foddai M, Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur J Neurosci. 2003;17:605–12.

    Article  PubMed  Google Scholar 

  48. Tepper JM, Sawyer SF, Groves PM. Electrophysiologically identified nigral dopaminergic neurons intracellularly labeled with HRP: light-microscopic analysis. J Neurosci. 1987;7:2794–806.

    CAS  PubMed  Google Scholar 

  49. Fallon JH. Collateralization of monoamine neurons: mesotelencephalic dopamine projections to caudate, septum, and frontal cortex. J Neurosci. 1981;1:1361–8.

    CAS  PubMed  Google Scholar 

  50. Fallon JH, Riley JN, Moore RY. Substantia nigra dopamine neurons: separate populations project to neostriatum and allocortex. Neurosci Lett. 1978;7:157–62.

    Article  CAS  PubMed  Google Scholar 

  51. Stamatakis AM, Jennings JH, Ung RL, Blair GA, Weinberg RJ, Neve RL, Boyce F, Mattis J, Ramakrishnan C, Deisseroth K, Stuber GD. A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron. 2013;80:1039–53.

    Article  CAS  PubMed  Google Scholar 

  52. Brown MT, Henny P, Bolam JP, Magill PJ. Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state. J Neurosci. 2009;29:2915–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Bunney BS, Walters JR, Roth RH, Aghajanian GK. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther. 1973;185:560–71.

    CAS  PubMed  Google Scholar 

  54. Guyenet PG, Aghajanian GK. Antidromic identification of dopaminergic and other output neurons of the rat substantia nigra. Brain Res. 1978;150:69–84.

    Article  CAS  PubMed  Google Scholar 

  55. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci. 1984;4:2877–90.

    CAS  PubMed  Google Scholar 

  56. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci. 1984;4:2866–76.

    CAS  PubMed  Google Scholar 

  57. Tepper JM, Nakamura S, Young SJ, Groves PM. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions. Brain Res. 1984;309:317–33.

    Article  CAS  PubMed  Google Scholar 

  58. Tepper JM, Young SJ, Groves PM. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of increases in impulse flow. Brain Res. 1984;309:309–16.

    Article  CAS  PubMed  Google Scholar 

  59. Gariano RF, Tepper JM, Sawyer SF, Young SJ, Groves PM. Mesocortical dopaminergic neurons. 1. Electrophysiological properties and evidence for soma-dendritic autoreceptors. Brain Res Bull. 1989;22:511–6.

    Article  CAS  PubMed  Google Scholar 

  60. Grace AA, Bunney BS. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization. Neuroscience. 1983;10:301–15.

    Article  CAS  PubMed  Google Scholar 

  61. Romo R, Schultz W. Dopamine neurons of the monkey midbrain: contingencies of responses to active touch during self-initiated arm movements. J Neurophysiol. 1990;63:592–606.

    CAS  PubMed  Google Scholar 

  62. Ungless MA, Grace AA. Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci. 2012;35:422–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Gonon FG. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 1988;24:19–28.

    Article  CAS  PubMed  Google Scholar 

  64. Lobb CJ, Wilson CJ, Paladini CA. A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J Neurophysiol. 2010;104:403–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Blythe SN, Atherton JF, Bevan MD. Synaptic activation of dendritic AMPA and NMDA receptors generates transient high-frequency firing in substantia nigra dopamine neurons in vitro. J Neurophysiol. 2007;97:2837–50.

    Article  CAS  PubMed  Google Scholar 

  66. Blythe SN, Wokosin D, Atherton JF, Bevan MD. Cellular mechanisms underlying burst firing in substantia nigra dopamine neurons. J Neurosci. 2009;29:15531–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Kitai ST, Shepard PD, Callaway JC, Scroggs R. Afferent modulation of dopamine neuron firing patterns. Curr Opin Neurobiol. 1999;9:690–7.

    Article  CAS  PubMed  Google Scholar 

  68. Zweifel LS, Parker JG, Lobb CJ, Rainwater A, Wall VZ, Fadok JP, Darvas M, Kim MJ, Mizumori SJ, Paladini CA, Phillips PE, Palmiter RD. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci U S A. 2009;106:7281–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L, Deisseroth K. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science. 2009;324:1080–4.

    Article  CAS  PubMed  Google Scholar 

  70. Watabe-Uchida M, Zhu L, Ogawa SK, Vamanrao A, Uchida N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron. 2012;74:858–73.

    Article  CAS  PubMed  Google Scholar 

  71. Fields HL, Hjelmstad GO, Margolis EB, Nicola SM. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci. 2007;30:289–316.

    Article  CAS  PubMed  Google Scholar 

  72. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev. 2007;56:27–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Redgrave P, Gurney K, Reynolds J. What is reinforced by phasic dopamine signals? Brain Res Rev. 2008;58:322–39.

    Article  CAS  PubMed  Google Scholar 

  74. Geisler S, Derst C, Veh RW, Zahm DS. Glutamatergic afferents of the ventral tegmental area in the rat. J Neurosci. 2007;27:5730–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Carr DB, Sesack SR. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci. 2000;20:3864–73.

    CAS  PubMed  Google Scholar 

  76. Georges F, Aston-Jones G. Potent regulation of midbrain dopamine neurons by the bed nucleus of the stria terminalis. J Neurosci. 2001;21:RC160.

    CAS  PubMed  Google Scholar 

  77. Georges F, Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci. 2002;22:5173–87.

    CAS  PubMed  Google Scholar 

  78. Jennings JH, Sparta DR, Stamatakis AM, Ung RL, Pleil KE, Kash TL, Stuber GD. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013;496:224–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Kaufling J, Veinante P, Pawlowski SA, Freund-Mercier MJ, Barrot M. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J Comp Neurol. 2009;513:597–621.

    Article  PubMed  Google Scholar 

  80. Jhou TC, Geisler S, Marinelli M, Degarmo BA, Zahm DS. The mesopontine rostromedial tegmental nucleus: a structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol. 2009;513:566–96.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Barrot M, Sesack SR, Georges F, Pistis M, Hong S, Jhou TC. Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions. J Neurosci. 2012;32:14094–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Bourdy R, Barrot M. A new control center for dopaminergic systems: pulling the VTA by the tail. Trends Neurosci. 2012;35:681–90.

    Article  CAS  PubMed  Google Scholar 

  83. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009;29:444–53.

    Article  CAS  PubMed  Google Scholar 

  84. Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci. 2004;24:10707–15.

    Article  CAS  PubMed  Google Scholar 

  85. Riegel AC, Lupica CR. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci. 2005;24:11070–8.

    Article  CAS  Google Scholar 

  86. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci. 2007;27:791–5.

    Article  CAS  PubMed  Google Scholar 

  87. Marinelli S, Pascucci T, Bernardi G, Puglisi-Allegra S, Mercuri NB. Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology. 2005;30:864–70.

    Article  CAS  PubMed  Google Scholar 

  88. Ungless MA, Magill PJ, Bolam JP. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science. 2004;303:2040–2.

    Article  CAS  PubMed  Google Scholar 

  89. Oleson EB, Cachope R, Fitoussi A, Cheer JF. Tales from the dark side: do neuromodulators of drug withdrawal require changes in endocannabinoid tone? Prog Neuropsychopharmacol Biol Psychiatry. 2013.

    Google Scholar 

  90. Valenti O, Grace AA. Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway. Int J Neuropsychopharmacol. 2010;13:845–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Egertova M, Simon GM, Cravatt BF, Elphick MR. Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: a new perspective on N-acylethanolamines as neural signaling molecules. J Comp Neurol. 2008;506:604–15.

    Article  CAS  PubMed  Google Scholar 

  92. Pan B, Hillard CJ, Liu QS. Endocannabinoid signaling mediates cocaine-induced inhibitory synaptic plasticity in midbrain dopamine neurons. J Neurosci. 2008;28:1385–97.

    Article  CAS  PubMed  Google Scholar 

  93. Melis M, De Felice M, Lecca S, Fattore L, Pistis M. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Front Integr Neurosci. 2013;7(93):1–13.

    Google Scholar 

  94. Fiorillo CD, Williams JT. Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature. 1998;394:78–82.

    Article  CAS  PubMed  Google Scholar 

  95. Overton PG, Clark D. Burst firing in midbrain dopaminergic neurons. Brain Res Brain Res Rev. 1997;25:312–34.

    Article  CAS  PubMed  Google Scholar 

  96. Cooper DC. The significance of action potential bursting in the brain reward circuit. Neurochem Int. 2002;41:333–40.

    Article  CAS  PubMed  Google Scholar 

  97. Castelli MP, Fadda P, Casu A, Spano MS, Casti A, Fratta W, Fattore L. Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr Pharm Des. 2013.

    Google Scholar 

  98. Schoenbaum G, Chiba AA, Gallagher M. Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning. Nat Neurosci. 1998;1:155–9.

    Article  CAS  PubMed  Google Scholar 

  99. Bechara A, Damasio H, Damasio AR, Lee GP. Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci. 1999;19:5473–81.

    CAS  PubMed  Google Scholar 

  100. van den Bos R, Homberg J, de Visser L. A critical review of sex differences in decision-making tasks: focus on the Iowa Gambling Task. Behav Brain Res. 2013;238:95–108.

    Article  PubMed  Google Scholar 

  101. Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Front Neuroendocrinol. in press.

    Google Scholar 

  102. Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci. 2011;8:73–96.

    Article  CAS  PubMed  Google Scholar 

  103. Harrison PJ, Tunbridge EM. Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology. 2008;33:3037–45.

    Article  CAS  PubMed  Google Scholar 

  104. Huang GZ, Woolley CS. Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron. 2012;74:801–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Vrticka P, Neely M, Walter Shelly E, Black JM, Reiss AL. Sex differences during humor appreciation in child-sibling pairs. Soc Neurosci. 2013;8:291–304.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Chung WC, Auger AP. Gender differences in neurodevelopment and epigenetics. Pflugers Arch. 2013;465:573–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology (Berl). 2009;201:471–81.

    Article  CAS  Google Scholar 

  108. Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology. 2012;37:1164–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Szabo B, Siemes S, Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci. 2002;15:2057–61.

    Article  PubMed  Google Scholar 

  110. Hong S, Jhou TC, Smith M, Saleem KS, Hikosaka O. Negative reward signals from the lateral habenula to dopamine neurons are mediated by rostromedial tegmental nucleus in primates. J Neurosci. 2011;31:11457–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron. 2009;61:786–800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Marinelli S, Di Marzo V, Berretta N, Matias I, Maccarrone M, Bernardi G, Mercuri NB. Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci. 2003;23:3136–44.

    CAS  PubMed  Google Scholar 

  113. Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J Neurosci. 2008;28:13985–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Haj-Dahmane S, Shen RY. Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons. J Physiol. 2010;588:2589–604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Kortleven C, Bruneau LC, Trudeau LE. Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. Neuropharmacology. 2012;63:983–91.

    Article  CAS  PubMed  Google Scholar 

  116. Labouebe G, Liu S, Dias C, Zou H, Wong JC, Karunakaran S, Clee SM, Phillips AG, Boutrel B, Borgland SL. Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids. Nat Neurosci. 2013;16:300–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Binder EB, Kinkead B, Owens MJ, Nemeroff CB. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biol Psychiatry. 2001;50:856–72.

    Article  CAS  PubMed  Google Scholar 

  118. D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004;29:1558–72.

    Article  PubMed  CAS  Google Scholar 

  119. Kolliakou A, Joseph C, Ismail K, Atakan Z, Murray RM. Why do patients with psychosis use cannabis and are they ready to change their use? Int J Dev Neurosci. 2011;29:335–46.

    Article  PubMed  Google Scholar 

  120. Lodge DJ, Grace AA. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci U S A. 2006;103:5167–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Schilstrom B, Rawal N, Mameli-Engvall M, Nomikos GG, Svensson TH. Dual effects of nicotine on dopamine neurons mediated by different nicotinic receptor subtypes. Int J Neuropsychopharmacol. 2003;6:1–11.

    Article  PubMed  CAS  Google Scholar 

  122. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP, Faure P. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron. 2006;50:911–21.

    Article  CAS  PubMed  Google Scholar 

  123. Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci. 1985;5:1307–15.

    CAS  PubMed  Google Scholar 

  124. Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biol Psychiatry. 2010;68:256–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Curr Med Chem. 2010;17:1450–67.

    Article  CAS  PubMed  Google Scholar 

  126. Ueda N, Puffenbarger RA, Yamamoto S, Deutsch DG. The fatty acid amide hydrolase (FAAH). Chem Phys Lipids. 2000;108:107–21.

    Article  CAS  PubMed  Google Scholar 

  127. Tsuboi K, Okamoto Y, Ikematsu N, Inoue M, Shimizu Y, Uyama T, Wang J, Deutsch DG, Burns MP, Ulloa NM, Tokumura A, Ueda N. Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim Biophys Acta. 2011;1811:565–77.

    Article  CAS  PubMed  Google Scholar 

  128. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez De Fonseca F, Rosengarth A, Luecke H, Di Giacomo B, Tarzia G, Piomelli D. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003;425:90–3.

    Article  CAS  PubMed  Google Scholar 

  129. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther. 2006;319:1051–61.

    Article  CAS  PubMed  Google Scholar 

  130. Lambert DM, Di Marzo V. The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr Med Chem. 1999;6:757–73.

    CAS  PubMed  Google Scholar 

  131. Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ. ‘Entourage’ effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol. 2002;136:452–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J. 2001;358:249–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. De Petrocellis L, Davis JB, Di Marzo V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett. 2001;506:253–6.

    Article  CAS  PubMed  Google Scholar 

  134. Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide. Br J Pharmacol. 2001;133:1263–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Hansen HH, Ikonomidou C, Bittigau P, Hansen SH, Hansen HS. Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J Neurochem. 2001;76:39–46.

    Article  CAS  PubMed  Google Scholar 

  136. Greene JG. Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J Physiol. 2006;575:411–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  137. Hauser MA, Li YJ, Xu H, Noureddine MA, Shao YS, Gullans SR, Scherzer CR, Jensen RV, McLaurin AC, Gibson JR, Scott BL, Jewett RM, Stenger JE, Schmechel DE, Hulette CM, Vance JM. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism. Arch Neurol. 2005;62:917–21.

    Article  PubMed  Google Scholar 

  138. Jin X, Costa RM. Start/stop signals emerge in nigrostriatal circuits during sequence learning. Nature. 2010;466:457–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Ward SJ, Dykstra LA. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol. 2005;16:381–8.

    Article  CAS  PubMed  Google Scholar 

  140. Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord. 2003;27:289–301.

    Article  CAS  PubMed  Google Scholar 

  141. Mahler SV, Smith KS, Berridge KC. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances ‘liking’ of a sweet reward. Neuropsychopharmacology. 2007;32:2267–78.

    Article  CAS  PubMed  Google Scholar 

  142. Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF, Lichtman AH, Cheer JF. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron. 2012;73:360–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. Bindra D. A unfied interpretation of emotion and motivation. Ann N Y Acad Sci. 1969;159:1071–83.

    Article  CAS  PubMed  Google Scholar 

  144. Kelley SP, Mittleman G. Effects of hippocampal damage on reward threshold and response rate during self-stimulation of the ventral tegmental area in the rat. Behav Brain Res. 1999;99:133–41.

    Article  CAS  PubMed  Google Scholar 

  145. Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A. Exercise activates the endocannabinoid system. Neuroreport. 2003;14:2209–11.

    Article  CAS  PubMed  Google Scholar 

  146. De Chiara V, Errico F, Musella A, Rossi S, Mataluni G, Sacchetti L, Siracusano A, Castelli M, Cavasinni F, Bernardi G, Usiello A, Centonze D. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. Neuropsychopharmacology. 2010;35:374–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Dubreucq S, Durand A, Matias I, Bénard G, Richard E, Soria-Gomez E, Glangetas C, Groc L, Wadleigh A, Massa F, Bartsch D, Marsicano G, Georges F, Chaouloff F. Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Biol Psychiatry. 2013;73:895–903.

    Article  CAS  PubMed  Google Scholar 

  148. Rasmussen EB, Hillman C. Naloxone and rimonabant reduce the reinforcing properties of exercise in rats. Exp Clin Psychopharmacol. 2011;19:389–400.

    Article  CAS  PubMed  Google Scholar 

  149. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A. 1999;96:5780–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  150. Kreitzer AC, Malenka RC. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson’s disease models. Nature. 2007;445:643–7.

    Article  CAS  PubMed  Google Scholar 

  151. Borgland SL, Chang SJ, Bowers MS, Thompson JL, Vittoz N, Floresco SB, Chou J, Chen BT, Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci. 2009;29:11215–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  152. Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, Roth RH, Sleeman MW, Picciotto MR, Tschöp MH, Gao XB, Horvath TL. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116:3229–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  153. Thompson JL, Borgland SL. A role for hypocretin/orexin in motivation. Behav Brain Res. 2011;217:446–53.

    Article  CAS  PubMed  Google Scholar 

  154. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci. 2004;24:53–62.

    Article  CAS  PubMed  Google Scholar 

  155. Neuhoff H, Neu A, Liss B, Roeper J. I(h) channels contribute to the different functional properties of identified dopaminergic subpopulations in the midbrain. J Neurosci. 2002;22:1290–302.

    CAS  PubMed  Google Scholar 

  156. Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology. 2011;36:589–602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  157. Floresco SB, Magyar O. Mesocortical dopamine modulation of executive functions: beyond working memory. Psychopharmacology (Berl). 2006;188:567–85.

    Article  CAS  Google Scholar 

  158. Liston C, Miller MM, Goldwater DS, Radley JJ, Rocher AB, Hof PR, Morrison JH, McEwen BS. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set-shifting. J Neurosci. 2006;26:7870–4.

    Article  CAS  PubMed  Google Scholar 

  159. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci. 2007;27:2781–7.

    Article  CAS  PubMed  Google Scholar 

  160. Butts KA, Weinberg J, Young AH, Phillips AG. Glucocorticoid receptors in the prefrontal cortex regulate stress-evoked dopamine efflux and aspects of executive function. Proc Natl Acad Sci U S A. 2011;108:18459–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  161. Butts KA, Floresco SB, Phillips AG. Acute stress impairs set-shifting but not reversal learning. Behav Brain Res. 2013;252:222–9.

    Article  CAS  PubMed  Google Scholar 

  162. Haller J, Varga B, Ledent C, Barna I, Freund TF. Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci. 2004;19:1906–12.

    Article  CAS  PubMed  Google Scholar 

  163. Patel S, Cravatt BF, Hillard CJ. Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala. Neuropsychopharmacology. 2005;30:497–507.

    Article  CAS  PubMed  Google Scholar 

  164. Aso E, Ozaita A, Valdizan EM, Ledent C, Pazos A, Maldonado R, Valverde O. BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J Neurochem. 2008;105:565–72.

    Article  CAS  PubMed  Google Scholar 

  165. Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, Hillard CJ, Gorzalka BB, Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci U S A. 2010;107:9406–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  166. Hill MN, Patel S, Campolongo P, Tasker JG, Wotjak CT, Bains JS. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J Neurosci. 2010;30:14980–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  167. Riebe CJ, Wotjak CT. Endocannabinoids and stress. Stress. 2011;14:384–97.

    Article  CAS  PubMed  Google Scholar 

  168. Dubreucq S, Matias I, Cardinal P, et al. Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. Neuropsychopharmacology. 2012;37:1885–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  169. Hill MN, Hillard CJ, McEwen BS. Alterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress. Cereb Cortex. 2011;21:2056–64.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Haller J, Bakos N. Stress-induced social avoidance: a new model of stress-induced anxiety? Physiol Behav. 2002;77:327–32.

    Article  CAS  PubMed  Google Scholar 

  171. Haller J, Bakos N, Rodriguiz RM, Caron MG, Wetsel WC, Liposits Z. Behavioral responses to social stress in noradrenaline transporter knockout mice: effects on social behavior and depression. Brain Res Bull. 2002;58:279–84.

    Article  CAS  PubMed  Google Scholar 

  172. Uriguen L, Perez-Rial S, Ledent C, Palomo T, Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology. 2004;46:966–73.

    Article  CAS  PubMed  Google Scholar 

  173. Steiner MA, Wanisch K, Monory K, Marsicano G, Borroni E, Bächli H, Holsboer F, Lutz B, Wotjak CT. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 2008;8:196–208.

    Article  CAS  PubMed  Google Scholar 

  174. Aso E, Ozaita A, Serra MA, Maldonado R. Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype. Eur Neuropsychopharmacol. 2011;21:11–22.

    Article  CAS  PubMed  Google Scholar 

  175. Kathuria S, Gaetani S, Fegley D, Valiño F, Duranti A, Tontini A, Mor M, Tarzia G, La Rana G, Calignano A, Giustino A, Tattoli M, Palmery M, Cuomo V, Piomelli D. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2003;9:76–81.

    Article  CAS  PubMed  Google Scholar 

  176. Moreira FA, Kaiser N, Monory K, Lutz B. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology. 2008;54:141–50.

    Article  CAS  PubMed  Google Scholar 

  177. Patel S, Roelke CT, Rademacher DJ, Hillard CJ. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci. 2005;21:1057–69.

    Article  PubMed  Google Scholar 

  178. Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology. 2008;54:108–16.

    Article  CAS  PubMed  Google Scholar 

  179. Robinson SA, Loiacono RE, Christopoulos A, Sexton PM, Malone DT. The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling. Brain Res. 2010;1343:153–67.

    Article  CAS  PubMed  Google Scholar 

  180. Glangetas C, Girard D, Groc L, Marsicano G, Chaouloff F, Georges F. Stress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis. J Neurosci. 2013;33:19657–63.

    Article  PubMed  Google Scholar 

  181. Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2010;35:105–35.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Massi L, Elezgarai I, Puente N, Reguero L, Grandes P, Manzoni OJ, Georges F. Cannabinoid receptors in the bed nucleus of the stria terminalis control cortical excitation of midbrain dopamine cells in vivo. J Neurosci. 2008;28:10496–508.

    Article  CAS  PubMed  Google Scholar 

  183. Puente N, Cui Y, Lassalle O, Lafourcade M, Georges F, Venance L, Grandes P, Manzoni OJ. Polymodal activation of the endocannabinoid system in the extended amygdala. Nat Neurosci. 2011;14:1542–7.

    Article  CAS  PubMed  Google Scholar 

  184. Butts KA, Phillips AG. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area. Int J Neuropsychopharmacol. 2013;16:1799–807.

    Article  CAS  PubMed  Google Scholar 

  185. Anstrom KK, Woodward DJ. Restraint increases dopaminergic burst firing in awake rats. Neuropsychopharmacology. 2005;30:1832–40.

    Article  CAS  PubMed  Google Scholar 

  186. Hu SS, Bradshaw HB, Benton VM, Chen JS, Huang SM, Minassi A, Bisogno T, Masuda K, Tan B, Roskoski R Jr, Cravatt BF, Di Marzo V, Walker JM. The biosynthesis of N-arachidonoyl dopamine (NADA), a putative endocannabinoid and endovanilloid, via conjugation of arachidonic acid with dopamine. Prostaglandins Leukot Essent Fatty Acids. 2009;81:291–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  187. Pan B, Hillard CJ, Liu QS. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci. 2008;28:14018–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IINS-UMR5297, CNRS, Bordeaux, France

    François Georges

  2. Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy

    Miriam Melis

Authors
  1. François Georges
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miriam Melis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to François Georges .

Editor information

Editors and Affiliations

  1. Dept. of Physiology and Pharmacology, Sapienza University, Rome, Italy

    Patrizia Campolongo

  2. Institute of Neuroscience CNR, University of Cagliari, Cagliari, Italy

    Liana Fattore

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Georges, F., Melis, M. (2015). Cannabinoid-Dopamine Interactions: Modulation of Midbrain DA Neurons by Endocannabinoids. In: Campolongo, P., Fattore, L. (eds) Cannabinoid Modulation of Emotion, Memory, and Motivation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2294-9_17

Download citation

Publish with us

Policies and ethics

Search

Navigation